Table 3. The effects of COVID-19 pandemic on the time intervals of the Door-to-Device procedure were examined using multivariate regression analysis, with adjustment for potential confounders.
Variables | 1. Door-to-ECG | 2. ECG-to-CCLA | 3. CCLA-to-CCLD | 4.2. Angio-to-Device | ||||
Betaa | pa | Betab | pb | Betaa | pa | Betab | pb | |
COVID-19 periods | ||||||||
Period-I | Ref | - | Ref | - | Ref | - | Ref | - |
Period-II | 0.10 | 0.601 | -0.11 | 0.914 | -0.02 | 0.988 | -2.60 | < 0.001* |
Period-III | 0.62 | 0.006* | 3.30 | 0.009* | 9.65 | < 0.001* | -4.08 | < 0.001* |
Sex, male to female | -0.68 | 0.013* | -0.42 | 0.743 | -1.80 | 0.292 | 0.70 | 0.307 |
CAD history | -0.56 | 0.042* | -1.39 | 0.319 | -0.41 | 0.845 | -0.43 | 0.616 |
Triage level, from 4 to 1 | -0.28 | 0.072 | -2.41 | < 0.001* | 1.88 | 0.05 | -0.46 | 0.267 |
GLM Tweediea or Gammab regression was appropriately employed based on the goodness-of-fit test for non-normally distributed independent variables.
CAD, coronary artery disease; CCLA, cardiac catheterization laboratory activation; CCLD, cardiac catheterization laboratory door; COVID-19, Coronavirus Disease 2019; ECG, electrocardiogram; ICU, intensive care unit.